Correlation Between Paxman AB and SpectraCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Paxman AB and SpectraCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Paxman AB and SpectraCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Paxman AB and SpectraCure AB, you can compare the effects of market volatilities on Paxman AB and SpectraCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Paxman AB with a short position of SpectraCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Paxman AB and SpectraCure.

Diversification Opportunities for Paxman AB and SpectraCure

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Paxman and SpectraCure is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Paxman AB and SpectraCure AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SpectraCure AB and Paxman AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Paxman AB are associated (or correlated) with SpectraCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SpectraCure AB has no effect on the direction of Paxman AB i.e., Paxman AB and SpectraCure go up and down completely randomly.

Pair Corralation between Paxman AB and SpectraCure

Assuming the 90 days trading horizon Paxman AB is expected to generate 0.1 times more return on investment than SpectraCure. However, Paxman AB is 10.51 times less risky than SpectraCure. It trades about 0.14 of its potential returns per unit of risk. SpectraCure AB is currently generating about -0.07 per unit of risk. If you would invest  7,120  in Paxman AB on April 24, 2025 and sell it today you would earn a total of  1,260  from holding Paxman AB or generate 17.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.36%
ValuesDaily Returns

Paxman AB  vs.  SpectraCure AB

 Performance 
       Timeline  
Paxman AB 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Paxman AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Paxman AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
SpectraCure AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days SpectraCure AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in August 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Paxman AB and SpectraCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Paxman AB and SpectraCure

The main advantage of trading using opposite Paxman AB and SpectraCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Paxman AB position performs unexpectedly, SpectraCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SpectraCure will offset losses from the drop in SpectraCure's long position.
The idea behind Paxman AB and SpectraCure AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges